Literature Scan

Literature Scan

New and noteworthy research from the medial literature landscape

A New Era for Waldenström’s Macroglobulinemia Treatment

In the more than 70 years since Jan G. Waldenström discovered Waldenström's macroglobulinemia, there have been few answers about what causes the malignant B-cell...

High-Cost Surveillance Imaging Falls Short on Survival Benefit in DLBCL

Surveillance imaging to monitor patients with diffuse large B-cell lymphoma (DLBCL) in first remission may be common practice, but a new cost-effectiveness analysis has...

How Costly is Febrile Neutropenia in Patients with Metastatic Cancer?

Febrile neutropenia (FN) is a frequent and often costly complication for patients with metastatic cancer receiving myelosuppressive chemotherapy. When patients develop FN, the likelihood...

Ruxolitinib: Another Option for Polycythemia Vera Patients with Poor RESPONSE

Patients with polycythemia vera who do not respond well to hydroxyurea may have another promising treatment option, according to results from the RESPONSE trial. A...

Newer TKIs Versus Imatinib in CML-CP Patients

With the emergence of second-generation tyrosine kinase inhibitors (TKIs), more choices than ever exist for treating patients with chronic-phase chronic myeloid leukemia (CML-CP). However,...

Do Clinical Trials Underreport Cancer Drug Toxicities?

Clinical trials may be underreporting patient toxicities from cancer drugs – by up to 75 percent in some cases – according to a new...

Order of Gene Mutation: Predicting What Cancer Will Do Next

Over the last decade, scientists have gained a much greater understanding of which genes acquire mutations in particular cancers. Now, new research is showing...

Can Genetic Sequencing Provide Insights into Disease and Hematopoiesis?

Sequencing of genomic data is increasingly becoming a valuable tool in identifying disease etiology in diagnostically challenging cases, as one research team discovered while...

A Zebrafish and Enhanced Imaging Captures How Blood Stem Cells Take Root

A research team from Boston Children Hospital’s Stem Cell Research Program has provided the first direct glimpse into how blood stem cells take root...

The Debate Rages on: Is Omitting Radiation Therapy from Hodgkin Lymphoma Good for Patients?

Although Hodgkin lymphoma (HL) is frequently treated with a combination of chemotherapy and radiation therapy, there is a movement towards omitting radiation therapy altogether....
Advertisement

Current Issue

September 2020 Volume 6, Issue 11

This issue features a look at the evolution of preprint platforms, an analysis of the economic and health consequences of the COVID-19 pandemic, and more.

Block title